BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX
| 中文名称 | BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX |
|---|---|
| 中文同义词 | BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX;化合物 ACTIVATED EG3 TAIL |
| 英文名称 | Butanedioic acid, 1-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl] 4-[2-[2-[2-[[[4-(triphenylmethyl)-1-piperazinyl]carbonyl]oxy]ethoxy]ethoxy]ethyl] ester |
| 英文同义词 | Butanedioic acid, 1-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl] 4-[2-[2-[2-[[[4-(triphenylmethyl)-1-piperazinyl]carbonyl]oxy]ethoxy]ethoxy]ethyl] ester;Activated EG3 Tail |
| CAS号 | 1380600-06-5 |
| 分子式 | C43H47N3O10 |
| 分子量 | 765.85 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1380600-06-5.mol |
| 结构式 | ![]() |
BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX 性质
| 沸点 | 826.5±75.0 °C(Predicted) |
|---|---|
| 密度 | 1.35±0.1 g/cm3(Predicted) |
| 酸度系数(pKa) | 5.66±0.10(Predicted) |
BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX 用途与合成方法
Activated EG3 Tail 可用于外显子跳跃寡聚物偶联物的合成。获得的寡聚物偶联物与人抗肌萎缩蛋白基因中选定的靶位点互补,可诱导外显子 51 跳跃。可用于肌肉萎缩症的研究。
![BUTANEDIOIC ACID, 1-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-HEXAHYDRO-1,3-DIOXO-4,7-METHANO-2H-ISOINDOL-2-YL] 4-[2-[2-[2-[[[4-(TRIPHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]OX 结构式](CAS/20210111/GIF/1380600-06-5.gif)